248
Participants
Start Date
August 31, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
GS-5885
GS-5885 30 mg tablet administered orally once daily
GS-9451
GS-9451 200 mg tablet administered orally once daily
RBV
Ribavirin (RBV) tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\< 75kg = 1000 mg and ≥ 75 kg = 1200 mg)
PEG
Pegylated interferon alfa-2a (PEG) 180 μg administered once weekly by subcutaneous injection
Liverpool Hospital, Sydney
Saint Vincents Hospital, Darlinghurst
Royal Prince Alfred Hospital, Camperdown
Concord Repatriation General Hospital, Concord
Westmead Hospital, Westmead
Nepean Hospital, Kingswood
Alfred Hospital, Melbourne
Monash Medical Centre, Melbourne
Royal Melbourne Hospital, Parkville
St. Vincent's Hospital, Sydney Ltd., Fitzroy
Austin Health, Department of Hepatology, Heidelberg
Box Hill Hospital, Melbourne
Waikato Hospital, Hamilton
Royal Brisbane Hospital Research Foundation, Herston
Greenslopes Private Hospital, Woolloongabba
Princess Alexandra Hospital, Woolloongabba
Flinders Medical Centre, Bedford Park
Sir Charles Gairdner Hospital, Nedlands
Fremantle Hospital, Fremantle
Weill Cornell College of Medicine, New York
Westchester Medical Center, Yonkers
North Shore University Hospital, Great Neck
Metropolitan Liver Diseases Center, Fairfax
Digestive and Liver Disease Specialists, Norfolk
Liver Institute of Virginia, Bon Secours Health System, Newport News
The University of North Carolina at Chapel Hill, Chapel Hill
Duke University, Durham
Asheville Gastroenterology Associates, P.A., Asheville
Indianapolis Gastroenterology Research Foundation, Indianapolis
The North Texas Research Institute, Arlington
Research Specialists of Texas, Houston
South Denver Gastroenterology, Englewood
University of Utah Pediatric Pulmonology, Salt Lake City
Impact Clinical Trials, Las Vegas
Axis Clinical Trials, Los Angeles
Axis Clinical Trials, Los Angeles
UCLA Medical Center, Los Angeles
V.A. Greater Los Angeles Healthcare System, Los Angeles
Research and Education, Inc., San Diego
Stanford University, Stanford
San Jose Gastroenterology, San Jose
UC Davis Medical Center, Sacramento
Oregon Health & Science University, Portland
Harborview Medical Center, Seattle
Commonwealth Clinical Studies, LLC, Brockton
St. George Hospital, Kogarah
Western Hospital, Footscray
University of Calgary, Calgary
University of Alberta, Edmonton
LAIR Centre, Vancouver
GIRI GI Research Institute, Vancouver
University of Manitoba, John Buhler Research Centre, Winnipeg
London Health Sciences, London
Toronto Liver Centre, Toronto
Auckland Hospital, Aukland
Lead Sponsor
Gilead Sciences
INDUSTRY